| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity | 2.36e-06 | 3 | 267 | 3 | GO:0008454 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 1.42e-05 | 40 | 267 | 6 | GO:0016709 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TMEM67 RAB11B KATNAL2 SPTAN1 RAB11A KIF4A ACTN1 FMNL2 JMY BICD1 PTPN4 DST KIF15 NDC80 PLEKHM2 MICAL3 PLK1 USH2A FMNL1 MICAL1 LMTK2 ANKRD23 SHROOM2 PTPRT CRMP1 KLHL5 RMDN1 PAK1 KIF4B SSH2 CTTN FRMD5 | 2.98e-05 | 1099 | 267 | 32 | GO:0008092 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX47 KATNAL2 ABCA12 SMC1A KIF4A CHD2 ABCA8 KIF15 SHPRH DNAH5 ABCC10 RAD17 DHX40 ANXA5 DNAH2 ZNFX1 IDE FANCM KIF4B SLFN11 | 2.40e-04 | 614 | 267 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 2.69e-04 | 94 | 267 | 7 | GO:0050660 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DDX47 RAB11B KATNAL2 ABCA12 ARL11 SMC1A RAB11A CHD2 ABCA8 KIF15 RHOBTB2 GNAZ DNAH5 ABCC10 RAD17 DHX40 ARL13A DNAH2 IDE FANCM MTIF2 RAB40C SLFN11 | 3.17e-04 | 775 | 267 | 23 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DDX47 RAB11B KATNAL2 ABCA12 ARL11 SMC1A RAB11A CHD2 ABCA8 KIF15 RHOBTB2 GNAZ DNAH5 ABCC10 RAD17 DHX40 ARL13A DNAH2 IDE FANCM NUDT13 MTIF2 RAB40C SLFN11 | 4.00e-04 | 839 | 267 | 24 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DDX47 RAB11B KATNAL2 ABCA12 ARL11 SMC1A RAB11A CHD2 ABCA8 KIF15 RHOBTB2 GNAZ DNAH5 ABCC10 RAD17 DHX40 ARL13A DNAH2 IDE FANCM NUDT13 MTIF2 RAB40C SLFN11 | 4.07e-04 | 840 | 267 | 24 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DDX47 RAB11B KATNAL2 ABCA12 ARL11 SMC1A RAB11A CHD2 ABCA8 KIF15 RHOBTB2 GNAZ DNAH5 ABCC10 RAD17 DHX40 ARL13A DNAH2 IDE FANCM NUDT13 MTIF2 RAB40C SLFN11 | 4.07e-04 | 840 | 267 | 24 | GO:0016818 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 4.97e-04 | 28 | 267 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | AADAC CPPED1 PDE2A PTER INPP4B PNPT1 PTPN4 PTPN13 PTPRA PTPRB PLCL2 ACP7 MBLAC2 POLE LCAT FANCM ANKZF1 PTPRT LIPA NT5C2 ABHD13 SLFN11 SSH2 | 5.55e-04 | 807 | 267 | 23 | GO:0016788 |
| GeneOntologyBiologicalProcess | microtubule-based process | ADCY10 TEKT3 TMEM67 KATNAL2 RIPOR2 CATSPERE IFT172 SMC1A RAB11A KIF4A ODAD4 ADCY3 BICD1 KAT2B DST KIF15 NDC80 WASHC5 TTC12 VPS13A PLK1 PPP2R3C DNAH5 DNAAF4 ANXA5 DNAH2 SPG11 NSUN7 CCNF CELSR2 RMDN1 PAK1 UHRF1 KIF4B CEP152 HYDIN | 1.04e-07 | 1058 | 266 | 36 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | TMEM67 KATNAL2 RIPOR2 IFT172 SMC1A RAB11A KIF4A ODAD4 BICD1 KAT2B DST KIF15 NDC80 WASHC5 TTC12 PLK1 PPP2R3C DNAH5 DNAAF4 DNAH2 CCNF RMDN1 PAK1 UHRF1 KIF4B CEP152 HYDIN | 7.46e-07 | 720 | 266 | 27 | GO:0000226 |
| GeneOntologyBiologicalProcess | organelle assembly | TEKT3 TMEM67 RIPOR2 IFT172 SMC1A RAB11A KIF4A ODAD4 BICD1 KAT2B KIF15 NDC80 WASHC5 TTC12 PLK1 DNAH5 RILPL2 DNAAF4 ARL13A DNAH2 SLITRK3 SPG11 ANKRD23 HPS3 EXOC5 CELSR3 CELSR2 HGS PRICKLE2 UHRF1 KIF4B CEP152 AP4M1 HCK HYDIN | 1.67e-06 | 1138 | 266 | 35 | GO:0070925 |
| GeneOntologyBiologicalProcess | microtubule-based movement | ADCY10 TEKT3 CATSPERE IFT172 KIF4A ODAD4 ADCY3 BICD1 DST KIF15 TTC12 VPS13A DNAH5 DNAAF4 ANXA5 DNAH2 SPG11 NSUN7 CELSR2 KIF4B HYDIN | 1.89e-06 | 493 | 266 | 21 | GO:0007018 |
| GeneOntologyBiologicalProcess | neuron development | ADCY10 TMEM67 RIPOR2 RAB11A CDH23 NCAM1 RYK FAM151B KAT2B DST WASHC5 NFIB CNTN5 VPS13A C3 PLXNA2 PLXNB1 SEMA3F SEMA4D FAT4 SLC4A7 ARHGEF28 NRDC DSCAM ROR2 SLITRK4 LMTK2 SLITRK3 SPG11 CAMK1 UST OPCML CRMP1 EFHC2 CELSR3 CELSR2 PAK1 PRICKLE2 CTTN SEZ6 | 5.17e-06 | 1463 | 266 | 40 | GO:0048666 |
| GeneOntologyBiologicalProcess | cilium movement | ADCY10 TEKT3 CATSPERE ODAD4 ADCY3 TTC12 VPS13A DNAH5 DNAAF4 ANXA5 DNAH2 NSUN7 CELSR2 HYDIN | 8.07e-06 | 261 | 266 | 14 | GO:0003341 |
| GeneOntologyBiologicalProcess | axonogenesis | ADCY10 NCAM1 RYK DST NFIB CNTN5 PLXNA2 PLXNB1 SEMA3F SEMA4D ARHGEF28 NRDC DSCAM SLITRK4 LMTK2 SLITRK3 SPG11 UST CELSR3 PAK1 CTTN | 1.57e-05 | 566 | 266 | 21 | GO:0007409 |
| GeneOntologyBiologicalProcess | neuron projection development | ADCY10 RIPOR2 RAB11A CDH23 NCAM1 RYK KAT2B DST WASHC5 NFIB CNTN5 VPS13A PLXNA2 PLXNB1 SEMA3F SEMA4D FAT4 ARHGEF28 NRDC DSCAM ROR2 SLITRK4 LMTK2 SLITRK3 SPG11 CAMK1 UST CRMP1 EFHC2 CELSR3 CELSR2 PAK1 PRICKLE2 CTTN SEZ6 | 2.33e-05 | 1285 | 266 | 35 | GO:0031175 |
| GeneOntologyBiologicalProcess | mitotic spindle assembly | 2.52e-05 | 92 | 266 | 8 | GO:0090307 | |
| GeneOntologyBiologicalProcess | mitotic spindle organization | RIPOR2 SMC1A RAB11A KIF4A KIF15 NDC80 PLK1 RMDN1 UHRF1 KIF4B | 2.73e-05 | 151 | 266 | 10 | GO:0007052 |
| GeneOntologyBiologicalProcess | cell morphogenesis | ADCY10 RIPOR2 CDH23 NCAM1 ACTN1 FMNL2 RYK DST NFIB CNTN5 VPS13A FMNL1 PLXNA2 PLXNB1 SEMA3F SEMA4D ARHGEF28 RILPL2 NRDC DSCAM SLITRK4 LMTK2 SLITRK3 SPG11 SHROOM2 UST LIPA CELSR3 CELSR2 PAK1 CTTN FGD6 HCK | 3.06e-05 | 1194 | 266 | 33 | GO:0000902 |
| GeneOntologyBiologicalProcess | spindle assembly | RIPOR2 SMC1A RAB11A KIF4A KIF15 NDC80 WASHC5 PLK1 UHRF1 KIF4B | 3.06e-05 | 153 | 266 | 10 | GO:0051225 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ADCY10 RIPOR2 CDH23 NCAM1 RYK DST NFIB CNTN5 PLXNA2 PLXNB1 SEMA3F SEMA4D ARHGEF28 NRDC DSCAM SLITRK4 LMTK2 SLITRK3 SPG11 UST CELSR3 CELSR2 PAK1 CTTN | 4.13e-05 | 748 | 266 | 24 | GO:0048667 |
| GeneOntologyBiologicalProcess | semaphorin-plexin signaling pathway | 5.38e-05 | 52 | 266 | 6 | GO:0071526 | |
| GeneOntologyBiologicalProcess | axon development | ADCY10 NCAM1 RYK DST NFIB CNTN5 PLXNA2 PLXNB1 SEMA3F SEMA4D ARHGEF28 NRDC DSCAM SLITRK4 LMTK2 SLITRK3 SPG11 UST CELSR3 PAK1 CTTN | 9.65e-05 | 642 | 266 | 21 | GO:0061564 |
| GeneOntologyBiologicalProcess | mitotic sister chromatid segregation | RIPOR2 SMC1A RAB11A KIF4A KAT2B KIF15 NDC80 PLK1 RMDN1 UHRF1 KIF4B | 1.02e-04 | 212 | 266 | 11 | GO:0000070 |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | RIPOR2 LIN7B DST NDC80 RHOBTB2 PLK1 RAB11FIP2 UST CD3G PAK1 PRICKLE2 EXOC4 | 1.35e-04 | 257 | 266 | 12 | GO:0007163 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization involved in mitosis | RIPOR2 SMC1A RAB11A KIF4A KIF15 NDC80 PLK1 RMDN1 UHRF1 KIF4B | 1.64e-04 | 187 | 266 | 10 | GO:1902850 |
| GeneOntologyBiologicalProcess | spindle organization | RIPOR2 SMC1A RAB11A KIF4A KIF15 NDC80 WASHC5 PLK1 RMDN1 UHRF1 KIF4B | 1.66e-04 | 224 | 266 | 11 | GO:0007051 |
| GeneOntologyBiologicalProcess | axonemal dynein complex assembly | 1.76e-04 | 41 | 266 | 5 | GO:0070286 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 2.04e-04 | 192 | 266 | 10 | GO:0050770 | |
| GeneOntologyBiologicalProcess | mitotic cytokinesis | 2.31e-04 | 95 | 266 | 7 | GO:0000281 | |
| GeneOntologyBiologicalProcess | synapse organization | ACTN1 RYK PTPN13 CNTN5 C3 PLXNB1 SEMA3F SEMA4D OGT DSCAM ROR2 SLITRK4 SLITRK3 SPG11 CAMK1 PTPRT CRMP1 PAK1 PRICKLE2 CTTN SEZ6 | 2.34e-04 | 685 | 266 | 21 | GO:0050808 |
| GeneOntologyBiologicalProcess | cytoskeleton-dependent cytokinesis | 2.46e-04 | 127 | 266 | 8 | GO:0061640 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ADCY10 NCAM1 RYK DST NFIB CNTN5 VPS13A PLXNA2 PLXNB1 SEMA3F SEMA4D ARHGEF28 NRDC DSCAM SLITRK4 LMTK2 SLITRK3 SPG11 UST CELSR3 CELSR2 PAK1 CTTN | 3.09e-04 | 802 | 266 | 23 | GO:0048812 |
| GeneOntologyCellularComponent | intercalated disc | 3.16e-05 | 68 | 276 | 7 | GO:0014704 | |
| GeneOntologyCellularComponent | microtubule organizing center | TMEM67 KATNAL2 IFT172 CTSC RAB11A CCDC18 CDH23 BIRC6 BICD1 KAT2B KIF15 NDC80 TTC12 PLK1 PPP2R3C USH2A RILPL2 DNAAF4 CRMP1 CCNF EFHC2 TRIM69 CDK5RAP3 USO1 PAK1 ZFYVE26 CEP152 EXOC4 | 3.62e-05 | 919 | 276 | 28 | GO:0005815 |
| GeneOntologyCellularComponent | midbody | NEXMIF KIF4A BIRC6 PTPN13 MICAL3 PLK1 MICAL1 CRMP1 EXOC5 KIF4B ZFYVE26 EXOC4 | 4.19e-05 | 222 | 276 | 12 | GO:0030496 |
| GeneOntologyCellularComponent | centrosome | TMEM67 CTSC RAB11A CCDC18 CDH23 BIRC6 BICD1 KAT2B KIF15 NDC80 TTC12 PLK1 PPP2R3C RILPL2 DNAAF4 CRMP1 CCNF TRIM69 CDK5RAP3 PAK1 ZFYVE26 CEP152 EXOC4 | 2.44e-04 | 770 | 276 | 23 | GO:0005813 |
| GeneOntologyCellularComponent | cell-cell contact zone | 2.49e-04 | 94 | 276 | 7 | GO:0044291 | |
| GeneOntologyCellularComponent | semaphorin receptor complex | 5.90e-04 | 13 | 276 | 3 | GO:0002116 | |
| GeneOntologyCellularComponent | fascia adherens | 5.90e-04 | 13 | 276 | 3 | GO:0005916 | |
| Domain | P-loop_NTPase | DDX47 ADCY10 RAB11B KATNAL2 ABCA12 MFHAS1 ARL11 SMC1A RAB11A KIF4A CHD2 ABCA8 KIF15 RHOBTB2 SHPRH GNAZ DNAH5 ABCC10 RAD17 MPP3 DHX40 ARL13A DNAH2 ZNFX1 FANCM UST MTIF2 RAB40C KIF4B SLFN11 HYDIN ELP4 | 7.71e-07 | 848 | 271 | 32 | IPR027417 |
| Domain | - | DDX47 ADCY10 RAB11B KATNAL2 ABCA12 MFHAS1 ARL11 SMC1A RAB11A CHD2 ABCA8 RHOBTB2 SHPRH GNAZ DNAH5 ABCC10 RAD17 MPP3 DHX40 ARL13A DNAH2 ZNFX1 FANCM MTIF2 RAB40C SLFN11 HYDIN ELP4 | 4.40e-06 | 746 | 271 | 28 | 3.40.50.300 |
| Domain | Glyco_transf_54 | 1.20e-05 | 4 | 271 | 3 | IPR006759 | |
| Domain | Glyco_transf_54 | 1.20e-05 | 4 | 271 | 3 | PF04666 | |
| Domain | DUF1220 | 1.32e-05 | 11 | 271 | 4 | PF06758 | |
| Domain | NBPF_dom | 1.32e-05 | 11 | 271 | 4 | IPR010630 | |
| Domain | NBPF | 1.32e-05 | 11 | 271 | 4 | PS51316 | |
| Domain | TPR | IFT172 ODAD4 TTC7B TTC12 VPS13A TTC38 OGT DNAAF4 DNAH2 P4HA1 RMDN1 | 3.00e-05 | 165 | 271 | 11 | PS50005 |
| Domain | TPR_REGION | IFT172 ODAD4 TTC7B TTC12 VPS13A TTC38 OGT DNAAF4 DNAH2 P4HA1 RMDN1 | 3.00e-05 | 165 | 271 | 11 | PS50293 |
| Domain | TPR-like_helical_dom | ADCY10 ATR IFT172 SRP68 ODAD4 TTC7B TTC12 TTC38 OGT DNAAF4 CCNF P4HA1 RMDN1 | 3.79e-05 | 233 | 271 | 13 | IPR011990 |
| Domain | - | ADCY10 ATR SRP68 ODAD4 TTC7B TTC12 TTC38 OGT DNAAF4 CCNF P4HA1 RMDN1 | 5.21e-05 | 207 | 271 | 12 | 1.25.40.10 |
| Domain | Spectrin_repeat | 5.53e-05 | 29 | 271 | 5 | IPR002017 | |
| Domain | SPEC | 9.06e-05 | 32 | 271 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 9.06e-05 | 32 | 271 | 5 | IPR018159 | |
| Domain | PTPc | 1.62e-04 | 36 | 271 | 5 | SM00194 | |
| Domain | Peptidase_M16_M | 2.10e-04 | 2 | 271 | 2 | PF16187 | |
| Domain | YDG | 2.10e-04 | 2 | 271 | 2 | PS51015 | |
| Domain | Peptidase_M16_M | 2.10e-04 | 2 | 271 | 2 | IPR032632 | |
| Domain | TTD | 2.10e-04 | 2 | 271 | 2 | PF12148 | |
| Domain | SRA | 2.10e-04 | 2 | 271 | 2 | SM00466 | |
| Domain | - | 2.10e-04 | 2 | 271 | 2 | 2.30.280.10 | |
| Domain | DM15 | 2.10e-04 | 2 | 271 | 2 | IPR006607 | |
| Domain | SRA_YDG | 2.10e-04 | 2 | 271 | 2 | IPR003105 | |
| Domain | SAD_SRA | 2.10e-04 | 2 | 271 | 2 | PF02182 | |
| Domain | DM15 | 2.10e-04 | 2 | 271 | 2 | SM00684 | |
| Domain | TTD_dom | 2.10e-04 | 2 | 271 | 2 | IPR021991 | |
| Domain | LAM_G_DOMAIN | 2.10e-04 | 38 | 271 | 5 | PS50025 | |
| Domain | DUF1220 | 2.38e-04 | 9 | 271 | 3 | SM01148 | |
| Domain | TYR_PHOSPHATASE_PTP | 2.38e-04 | 39 | 271 | 5 | PS50055 | |
| Domain | Laminin_G_2 | 2.69e-04 | 40 | 271 | 5 | PF02210 | |
| Domain | PTPase_domain | 3.03e-04 | 41 | 271 | 5 | IPR000242 | |
| Domain | Y_phosphatase | 3.03e-04 | 41 | 271 | 5 | PF00102 | |
| Domain | Spectrin | 3.09e-04 | 23 | 271 | 4 | PF00435 | |
| Domain | LamG | 4.24e-04 | 44 | 271 | 5 | SM00282 | |
| Domain | Glutaredoxin_euk/vir | 6.23e-04 | 3 | 271 | 2 | IPR011899 | |
| Domain | EGF_LAM_2 | 8.83e-04 | 30 | 271 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 8.83e-04 | 30 | 271 | 4 | PS01248 | |
| Domain | SEMA | 1.00e-03 | 31 | 271 | 4 | PS51004 | |
| Domain | Semap_dom | 1.00e-03 | 31 | 271 | 4 | IPR001627 | |
| Domain | Sema | 1.00e-03 | 31 | 271 | 4 | SM00630 | |
| Domain | Sema | 1.00e-03 | 31 | 271 | 4 | PF01403 | |
| Pathway | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | 4.84e-05 | 15 | 201 | 4 | MM15700 | |
| Pathway | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | 4.84e-05 | 15 | 201 | 4 | M966 | |
| Pubmed | 3.37e-14 | 21 | 280 | 9 | 16079250 | ||
| Pubmed | EPRS1 PDE2A SPTAN1 SRP68 NCAM1 ACTN1 FMNL2 PTGS2 JMY PTPRA DST TTC7B WASHC5 NMT2 MICAL3 GNAZ MICAL1 OGT NRDC ARHGAP23 DSP LARP1 ZNFX1 SHROOM2 OPCML YARS1 CRMP1 PRKRA SLC25A12 USO1 KCTD10 PRICKLE2 SSH2 CTTN HCK EXOC4 HDLBP | 4.54e-10 | 1431 | 280 | 37 | 37142655 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | NBPF12 NBPF14 UNC79 NBPF8 SEMA3F XPNPEP1 LARP1B NBPF11 NBPF1 NBPF9 HGS NBPF10 HYDIN | 1.46e-09 | 170 | 280 | 13 | 23314748 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DDX47 EPRS1 NOC2L SMC1A SPTAN1 KIF4A SRP68 CHD2 ACTN1 BIRC6 DST PSME4 WASHC5 GLS SF3A3 POLR1B PLK1 NUP160 ALOX12B DNMT1 ARHGAP23 DSP DHX40 POLE ANXA5 AGPS IFI16 PRKRA METTL13 SLC25A12 ASS1 NUP133 EXOC4 HDLBP | 5.03e-09 | 1353 | 280 | 34 | 29467282 |
| Pubmed | EPRS1 PDE2A IFT172 SMC1A SPTAN1 ACTN1 FMNL2 BICD1 PTPN13 PTPRA DST TTC7B NMT2 GLS DNMT1 SEMA4D OGT DSCAM DSP RBL2 ZNFX1 GRIK1 CAMK1 SHROOM2 YARS1 CRMP1 PRKRA CELSR3 GUCY1B1 MTIF2 PAK1 CTTN EXOC4 | 5.10e-09 | 1285 | 280 | 33 | 35914814 | |
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 7.96e-09 | 10 | 280 | 5 | 22973535 | |
| Pubmed | EPRS1 MGAT4B ATR DST PSME4 WASHC5 CARD6 MICAL3 PLXNB1 DNMT1 OGT ARHGEF28 NRDC ARHGAP23 DHX40 POLE LARP1 ZNFX1 ANKZF1 MTIF2 UGGT2 EXOC4 | 1.95e-08 | 650 | 280 | 22 | 38777146 | |
| Pubmed | TDRD15 RAB11B ARL11 RAB11A LCN8 KIF4A SRP68 NCAM1 FMNL2 BIRC6 DMXL1 PTPN13 DST PLEKHM2 VPS13A NUP160 ARAP2 DNMT1 FAT4 SLC4A7 DSCAM AGPS USO1 AP4M1 | 2.46e-08 | 777 | 280 | 24 | 35844135 | |
| Pubmed | SPTAN1 CCDC18 BCOR BIRC6 TDRD3 PTPN4 WWC2 PTPN13 PTPRA PTPRB TTC7B KIF15 WASHC5 PLCL2 VPS13A MICAL3 PLK1 DNMT1 DSP LMTK2 IDE PTPRT P4HA1 HGS NUP133 SLFN11 SSH2 HDLBP | 3.61e-08 | 1049 | 280 | 28 | 27880917 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PDE2A MGAT4B MFHAS1 BIRC6 TDRD3 DST PSME4 PLEKHM2 MICAL3 GNAZ MCF2L PPP2R3C TTC38 ABCC10 MPP3 SEMA3F POLE LMTK2 SPATA20 PPARA NBPF1 NADSYN1 MROH1 CELSR3 CELSR2 TXNRD3 LRP3 ZFYVE26 | 1.06e-07 | 1105 | 280 | 28 | 35748872 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DDX47 CHD2 TGM5 PTPRB KIF15 SHPRH MICAL3 PLK1 SLITRK4 SPG11 MON1A NSUN7 LOXHD1 SLC25A12 P4HA1 ASS1 CTTN HYDIN | 1.46e-07 | 497 | 280 | 18 | 36774506 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TSHZ2 CHD2 ADCY3 BICD1 PTPN4 PTPN13 PTPRB TECPR2 NFIB TTC12 SHPRH MICAL3 GNAZ MCF2L SEMA4D MBLAC2 OGT ROR2 LARP1 SLITRK3 GRIK1 IDE PPARA SHROOM2 HPS3 NBPF1 NADSYN1 ASS1 NT5C2 CDYL2 SLC35F2 FBXO21 EXOC4 | 1.64e-07 | 1489 | 280 | 33 | 28611215 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SPTAN1 CCDC18 DPP8 PTER WWC2 PTPN13 DST PLK1 ARAP2 DNMT1 SLC4A7 ARHGEF28 DSP ROR2 RAB11FIP2 LMTK2 LARP1 LARP1B USO1 ASS1 CEP152 SSH2 FGD6 EXOC4 | 1.64e-07 | 861 | 280 | 24 | 36931259 |
| Pubmed | RIPOR2 ACTN1 ADCY3 PTPN13 DST PSME4 SF3A3 PPP2R3C SLC4A7 DSP CRMP1 KLHL5 EBP LRP3 | 4.24e-07 | 322 | 280 | 14 | 26514267 | |
| Pubmed | 5.16e-07 | 3 | 280 | 3 | 33848395 | ||
| Pubmed | SMC1A FMNL2 BIRC6 ABCA8 GLS TXNDC16 MICAL3 NUP160 ARHGEF28 ARHGAP23 FANCM WDFY4 METTL13 CEP152 SSH2 FGD6 EXOC4 | 6.44e-07 | 493 | 280 | 17 | 15368895 | |
| Pubmed | 7.66e-07 | 63 | 280 | 7 | 20301682 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | EPRS1 RAB11B CTSC CD109 SRP68 CHD2 OLFML3 PNPT1 GLS SF3A3 GNAZ SEMA3F SLC4A7 ARHGAP23 DSP OAS2 GLRX2 AGPS LGALS3BP SLC25A12 CELSR2 USO1 P4HA1 MTIF2 EBP ASS1 NT5C2 UGGT2 SARAF CTTN HDLBP | 8.69e-07 | 1451 | 280 | 31 | 30550785 |
| Pubmed | SMC1A SPTAN1 KIF4A SRP68 PNPT1 BTNL3 SHPRH SF3A3 PLK1 NUP160 SEMA3F FAT4 DSP ANXA5 DNAH2 NUDT13 YARS1 CRMP1 PRICKLE2 EXOC4 HDLBP | 1.01e-06 | 754 | 280 | 21 | 35906200 | |
| Pubmed | NBPF12 ABCA12 IFT172 SPTAN1 DST KIF15 NBPF14 NBPF8 FAT4 ARHGAP23 NBPF11 LGALS3BP NBPF1 CELSR3 NBPF9 NBPF10 LRRC37B | 1.11e-06 | 513 | 280 | 17 | 25798074 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | KIF4A SRP68 DST PSME4 SHPRH NUP160 NRDC NADSYN1 SLC25A12 KCTD10 NUP133 | 1.36e-06 | 212 | 280 | 11 | 33853758 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DDX47 EPRS1 NOC2L SMC1A SPTAN1 CD109 SRP68 ACTN1 DST GLS SF3A3 POLR1B C3 UHRF2 NUP160 DNMT1 DSG3 DSP LARP1 IFI16 YARS1 LGALS3BP PRKRA KCTD10 ASS1 NUP133 CTTN HDLBP | 1.37e-06 | 1257 | 280 | 28 | 36526897 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DDX47 ATR SMC1A SPTAN1 KIF4A SRP68 NDC80 SF3A3 PLK1 DSP POLE EXOC5 METTL13 USO1 PAK1 CTTN EXOC4 HDLBP | 1.43e-06 | 582 | 280 | 18 | 20467437 |
| Pubmed | 1.57e-06 | 100 | 280 | 8 | 10048485 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | TMEM67 MGAT4B ATR CTSC CD109 KIF4A NBPF26 DMXL1 TXNDC16 ECEL1 PLXNB1 DNMT1 SEMA3F FAT4 ROR2 SLITRK4 UST LGALS3BP CELSR3 CELSR2 P4HA1 EBP UHRF1 UGGT2 SARAF FRMD5 PROS1 | 1.80e-06 | 1201 | 280 | 27 | 35696571 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | IFT172 SPTAN1 DMXL1 TDRD3 TTC7B WASHC5 NMT2 C3 MCF2L FMNL1 DNMT1 ARHGAP23 DSP PRKRA MTIF2 HDLBP | 1.87e-06 | 475 | 280 | 16 | 31040226 |
| Pubmed | Final stages of cytokinesis and midbody ring formation are controlled by BRUCE. | 1.93e-06 | 12 | 280 | 4 | 18329369 | |
| Pubmed | Rab11 and its effector Rip11 participate in regulation of insulin granule exocytosis. | 2.05e-06 | 4 | 280 | 3 | 19335615 | |
| Pubmed | 2.05e-06 | 4 | 280 | 3 | 20877282 | ||
| Pubmed | 2.05e-06 | 4 | 280 | 3 | 28125646 | ||
| Pubmed | TRPM6 EPRS1 RIPOR2 CHD2 BCOR ADCY3 PTGS2 WWC2 PTPN13 PSME4 PLCL2 PLXNB1 RAD17 OGT SLC4A7 NRDC LMTK2 SHROOM2 PRAMEF13 WDFY4 CRMP1 KLHL5 CDK5RAP3 CELF1 SLC35F2 | 2.83e-06 | 1084 | 280 | 25 | 11544199 | |
| Pubmed | 3.85e-06 | 52 | 280 | 6 | 26633812 | ||
| Pubmed | 5.10e-06 | 5 | 280 | 3 | 18981235 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | EPRS1 MICOS13 NOC2L SMC1A RAB11A KIF4A ODAD4 SF3A3 UNC79 NUP160 OGT SLC4A7 DSP POLE RAB11FIP2 LARP1 YARS1 LGALS3BP PRKRA METTL13 CDK5RAP3 LOXHD1 SLC25A12 USO1 NUP133 EXOC4 HDLBP | 6.15e-06 | 1284 | 280 | 27 | 17353931 |
| Pubmed | SMC1A CCDC18 BIRC6 FBXO30 TDRD3 NDC80 WASHC5 POLE NUP133 CEP152 ELP4 | 6.88e-06 | 251 | 280 | 11 | 29778605 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | EPRS1 SMC1A CTSC SPTAN1 SRP68 ACTN1 DPP8 BIRC6 PSME4 KIF15 WASHC5 GLS SF3A3 NUP160 OGT NRDC LARP1 XPNPEP1 IDE UBR7 YARS1 CRMP1 HGS ASS1 NT5C2 NUP133 CTTN ELP4 HDLBP | 7.62e-06 | 1455 | 280 | 29 | 22863883 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | EPRS1 SPTAN1 SRP68 KIF15 PLK1 SLC4A7 DSP LARP1 CTTN ELP4 HDLBP | 8.29e-06 | 256 | 280 | 11 | 33397691 |
| Pubmed | TRPM6 BCL2L14 COPZ2 DPP8 TGM5 DMXL1 KAT2B PTPRA ECEL1 PLK1 DNAH5 SEMA4D DNAH2 KLHL5 LIPA KCTD10 PAK1 SSH2 HCK | 8.75e-06 | 730 | 280 | 19 | 34857952 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | EPRS1 NEXMIF SRP68 CHD2 FMNL2 BIRC6 TDRD3 DST VPS13A LAMB4 FAT4 DSP DNAH2 LARP1 AGPS LOXHD1 P4HA1 PRICKLE2 ELP4 | 9.82e-06 | 736 | 280 | 19 | 29676528 |
| Pubmed | Alternative Functions of Cell Cycle-Related and DNA Repair Proteins in Post-mitotic Neurons. | 9.88e-06 | 61 | 280 | 6 | 34746147 | |
| Pubmed | 1.01e-05 | 6 | 280 | 3 | 22411829 | ||
| Pubmed | Does 3D Phenotyping Yield Substantial Insights in the Genetics of the Mouse Mandible Shape? | 1.15e-05 | 18 | 280 | 4 | 26921296 | |
| Pubmed | EPRS1 SPTAN1 KIF4A SRP68 ACTN1 BCOR PTPN13 PLK1 DNMT1 OGT DSP LARP1 CTTN ELP4 EXOC4 HDLBP | 1.15e-05 | 549 | 280 | 16 | 38280479 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | DDX47 EPRS1 IBA57 SMC1A SPTAN1 RAB11A KIF4A SRP68 ACTN1 PTER BIRC6 PNPT1 SF3A3 DNMT1 OGT SLC4A7 NRDC DSP ANXA5 LARP1 ANKZF1 YARS1 LGALS3BP MRPS10 USO1 ASS1 CTTN HDLBP | 1.26e-05 | 1415 | 280 | 28 | 28515276 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRPM6 DDX47 EPRS1 ATR NOC2L SMC1A SPTAN1 RAB11A SRP68 GLS SF3A3 DNAH5 NUP160 DNMT1 NRDC DSP POLE ANXA5 LARP1 IDE AGPS YARS1 METTL13 USO1 NUP133 UHRF1 CTTN HDLBP | 1.43e-05 | 1425 | 280 | 28 | 30948266 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | EPRS1 SPTAN1 ACTN1 ABCA8 PTPN13 PSME4 C3 OGT DSP PRAMEF13 YARS1 EXOC5 SLC25A12 MROH1 CTTN EXOC4 | 1.61e-05 | 564 | 280 | 16 | 21565611 |
| Pubmed | MFHAS1 SPTAN1 SRP68 DST VPS13A FMNL1 SLC4A7 DSP ROR2 LARP1 CDK5RAP3 EBP CTTN ELP4 EXOC4 HDLBP | 1.75e-05 | 568 | 280 | 16 | 37774976 | |
| Pubmed | Identification of a novel Rab11/25 binding domain present in Eferin and Rip proteins. | 1.76e-05 | 7 | 280 | 3 | 11481332 | |
| Pubmed | Early embryonic expression patterns of the mouse Flamingo and Prickle orthologues. | 1.76e-05 | 7 | 280 | 3 | 17937400 | |
| Pubmed | 1.76e-05 | 7 | 280 | 3 | 22064703 | ||
| Pubmed | 1.83e-05 | 101 | 280 | 7 | 18519826 | ||
| Pubmed | RAB11A SRP68 CHD2 BCOR PTER NFIB GLS VPS13A MCF2L PPP2R3C FAT4 DHX40 POLE DNAH2 ZNFX1 IDE SLFN11 | 1.94e-05 | 638 | 280 | 17 | 31182584 | |
| Pubmed | DDX47 EPRS1 CTSC SPTAN1 SRP68 CHD2 FMNL2 FBXO30 DUS2 PNPT1 DNMT1 DSP ANXA5 LARP1 AGPS LARP1B ANKZF1 LGALS3BP PRKRA MRPS10 METTL13 USO1 P4HA1 EBP UHRF1 FBXO21 HDLBP | 1.97e-05 | 1371 | 280 | 27 | 36244648 | |
| Pubmed | CTSC SPTAN1 CD109 SRP68 BIRC6 TDRD3 DST GLS C3 ECEL1 NUP160 DNMT1 NRDC DSP LARP1 AGPS ANKZF1 YARS1 LGALS3BP METTL13 P4HA1 HGS EBP ASS1 NT5C2 UGGT2 | 2.09e-05 | 1297 | 280 | 26 | 33545068 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | EPRS1 NOC2L SMC1A SPTAN1 KIF4A SRP68 CHD2 SHPRH OGT YARS1 CELF1 UHRF1 EXOC4 | 2.16e-05 | 394 | 280 | 13 | 27248496 |
| Pubmed | FBXO30 NBPF19 DST TTC7B PLEKHM2 DNAH2 ANKZF1 SHROOM2 PRICKLE2 ANO7 | 2.16e-05 | 233 | 280 | 10 | 37704626 | |
| Pubmed | NOC2L SPTAN1 KIF4A SRP68 CHD2 ACTN1 BIRC6 PNPT1 DST NUP160 DNMT1 DSP POLE LARP1 PRKRA NUP133 HDLBP | 2.61e-05 | 653 | 280 | 17 | 22586326 | |
| Pubmed | 2.81e-05 | 8 | 280 | 3 | 14657349 | ||
| Pubmed | 2.81e-05 | 8 | 280 | 3 | 16545802 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | IFT172 SMC1A CDH23 SRP68 ACTN1 DPP8 FMNL2 FBXO30 PTPN13 PLCL2 SF3A3 C3 PLK1 NUP160 OGT DNAAF4 ANXA5 RAB11FIP2 LARP1 EFHC2 EXOC5 EBP NUP133 UGGT2 FGD6 EXOC4 | 2.85e-05 | 1321 | 280 | 26 | 27173435 |
| Pubmed | DDX47 EPRS1 CTSC KIF4A NCAM1 BIRC6 ADCY3 KIF15 NDC80 FMNL1 ANXA5 LARP1 OAS2 AGPS ANKZF1 IFI16 PRKRA CDK5RAP3 CELF1 USO1 P4HA1 NUP133 ABHD13 EXOC4 | 2.97e-05 | 1168 | 280 | 24 | 19946888 | |
| Pubmed | 3.28e-05 | 151 | 280 | 8 | 17043677 | ||
| Pubmed | 3.42e-05 | 197 | 280 | 9 | 21386911 | ||
| Pubmed | 3.80e-05 | 47 | 280 | 5 | 35462405 | ||
| Pubmed | SMC1A FCSK PSME4 WASHC5 SYCP1 ANXA5 GPT XPNPEP1 IDE NADSYN1 EXOC4 | 4.05e-05 | 304 | 280 | 11 | 32235678 | |
| Pubmed | PDE2A SPTAN1 KIF4A NCAM1 BCOR TDRD3 DST KIF15 UNC79 DNMT1 OGT DSCAM SPATA20 ZNFX1 CRMP1 CELSR2 NT5C2 PAK1 KIF4B SSH2 CTTN | 4.08e-05 | 963 | 280 | 21 | 28671696 | |
| Pubmed | 4.74e-05 | 117 | 280 | 7 | 17145500 | ||
| Pubmed | EPRS1 SMC1A SPTAN1 SRP68 SF3A3 NUP160 OGT DSP ANXA5 LARP1 LGALS3BP PRKRA USO1 NUP133 | 5.50e-05 | 494 | 280 | 14 | 26831064 | |
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 18332254 | ||
| Pubmed | KIF4 regulates neuronal morphology and seizure susceptibility via the PARP1 signaling pathway. | 6.46e-05 | 2 | 280 | 2 | 36482480 | |
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 19584262 | ||
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 36893815 | ||
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 28692051 | ||
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 17006639 | ||
| Pubmed | The multiple functions of kinesin-4 family motor protein KIF4 and its clinical potential. | 6.46e-05 | 2 | 280 | 2 | 30081192 | |
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 34546511 | ||
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 15880602 | ||
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 33945512 | ||
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 10790539 | ||
| Pubmed | Cellular motor protein KIF-4 associates with retroviral Gag. | 6.46e-05 | 2 | 280 | 2 | 10559369 | |
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 21565503 | ||
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 39443302 | ||
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 23699507 | ||
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 23303955 | ||
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 30081747 | ||
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 26051877 | ||
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 20071580 | ||
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 23168409 | ||
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 26966010 | ||
| Pubmed | p21-activated kinase 1 restricts tonic endocannabinoid signaling in the hippocampus. | 6.46e-05 | 2 | 280 | 2 | 27296803 | |
| Pubmed | A Role of myosin Vb and Rab11-FIP2 in the aquaporin-2 shuttle. | 6.46e-05 | 2 | 280 | 2 | 17156409 | |
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 12406905 | ||
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 32726623 | ||
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 15173169 | ||
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 10773663 | ||
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 20015870 | ||
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 27049577 | ||
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 28350061 | ||
| Pubmed | Inhibition of Sema4D/PlexinB1 signaling alleviates vascular dysfunction in diabetic retinopathy. | 6.46e-05 | 2 | 280 | 2 | 31943789 | |
| Pubmed | 6.46e-05 | 2 | 280 | 2 | 35151027 | ||
| Interaction | TOP3B interactions | EPRS1 PDE2A MGAT4B MICOS13 MFHAS1 NOC2L SMC1A SPTAN1 ACTN1 BIRC6 TDRD3 DST PSME4 NDC80 PLEKHM2 MICAL3 GNAZ MCF2L PPP2R3C TTC38 ABCC10 MPP3 SEMA3F POLE LMTK2 SPATA20 PPARA YARS1 NBPF1 CCNF NADSYN1 MROH1 CELSR3 CELSR2 CELF1 P4HA1 RMDN1 TXNRD3 LRP3 ZFYVE26 EXOC4 HDLBP | 4.91e-06 | 1470 | 277 | 42 | int:TOP3B |
| Cytoband | 1q21.1 | 3.97e-05 | 62 | 280 | 5 | 1q21.1 | |
| GeneFamily | Neuroblastoma breakpoint family | NBPF12 NBPF26 NBPF19 NBPF14 NBPF8 NBPF11 NBPF20 NBPF1 NBPF9 NBPF10 | 2.10e-14 | 23 | 199 | 10 | 662 |
| GeneFamily | Mannosyl-glycoprotein N-acetylglucosaminyltransferases | 1.05e-04 | 9 | 199 | 3 | 435 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 3.59e-04 | 3 | 199 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 3.59e-04 | 3 | 199 | 2 | 1189 | |
| GeneFamily | Tudor domain containing | 7.08e-04 | 37 | 199 | 4 | 780 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 1.51e-03 | 21 | 199 | 3 | 813 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.72e-03 | 115 | 199 | 6 | 769 | |
| GeneFamily | Fibronectin type III domain containing | 1.99e-03 | 160 | 199 | 7 | 555 | |
| GeneFamily | La ribonucleoprotein domain containing|RNA binding motif containing | 2.44e-03 | 7 | 199 | 2 | 625 | |
| GeneFamily | EF-hand domain containing|Plakins | 3.23e-03 | 8 | 199 | 2 | 939 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 4.12e-03 | 9 | 199 | 2 | 1234 | |
| GeneFamily | Exocyst complex | 4.12e-03 | 9 | 199 | 2 | 1055 | |
| GeneFamily | Plexins | 4.12e-03 | 9 | 199 | 2 | 683 | |
| Coexpression | GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP | NCAM1 DPP8 PTER TDRD3 C3 GNAZ LY86 YARS1 EFHC2 MRPS10 GUCY1B1 CTTN PROS1 | 2.38e-07 | 198 | 280 | 13 | M5774 |
| Coexpression | GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP | MFHAS1 JMY RYK FBXO30 WWC2 PLK1 PLXNA2 ASB17 ARHGAP23 GLRX2 XPNPEP1 CELF1 | 1.80e-06 | 200 | 280 | 12 | M7525 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | RIPOR2 TSHZ2 NCAM1 FMNL2 CNTN5 MICAL3 GNAZ MCF2L UNC79 MGAT4C MPP3 MBLAC2 DSCAM ARHGAP23 SLITRK4 GRIK1 LARP1B SHROOM2 OPCML PTPRT CRMP1 EFHC2 SLC32A1 SLC25A12 CELSR3 CELF1 PRICKLE2 SSH2 HYDIN FRMD5 | 3.08e-06 | 1106 | 280 | 30 | M39071 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ATR RYK BICD1 TDRD3 PTPN4 PTPN13 PTPRA DST PSME4 NDC80 NFIB NMT2 VPS13A MICAL3 NBPF14 NUP160 ARAP2 OGT SLC4A7 SPG11 UST SLC25A12 MTIF2 NT5C2 NUP133 | 6.13e-06 | 856 | 280 | 25 | M4500 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | SMC1A SPTAN1 KIF4A DST KIF15 NDC80 PLK1 SHROOM2 SSH2 CTTN FGD6 | 1.06e-05 | 199 | 280 | 11 | M5893 |
| Coexpression | GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP | PDE2A DMXL1 USH2A MGAT4C CMKLR2 OGT SLC4A7 ROR2 AGPS ASS1 NT5C2 | 1.11e-05 | 200 | 280 | 11 | M5192 |
| Coexpression | GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_UP | EPRS1 CPPED1 ARL11 KAT2B PLCL2 RBL2 HPS3 CDK5RAP3 PAK1 SARAF SLFN11 | 1.11e-05 | 200 | 280 | 11 | M3142 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | NEXMIF CCDC18 KIF4A NCAM1 BICD1 NDC80 GNAZ PLK1 UNC79 DNMT1 POLE FANCM UBR7 YARS1 CRMP1 CELSR3 CELSR2 NT5C2 UHRF1 KIF4B SEZ6 | 1.53e-05 | 680 | 280 | 21 | MM456 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | COPZ2 MFHAS1 EMILIN2 CYP46A1 ADCY3 FBXL21P PTPRB GNAZ FMNL1 SEMA3F SEMA4D ROR2 SLITRK4 LMTK2 NSUN7 SLC32A1 PRICKLE2 | 2.57e-05 | 493 | 280 | 17 | M1951 |
| Coexpression | NUYTTEN_NIPP1_TARGETS_UP | CTSC PTGS2 PNPT1 TTC7B GLS ARAP2 LAMB4 OGT OAS2 GLRX2 ZNFX1 IFI16 NUDT13 SLC25A12 CELF1 P4HA1 KCTD10 HGS SLC35F2 ZFYVE26 FRMD5 PROS1 | 3.01e-05 | 768 | 280 | 22 | M6444 |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2 | COPZ2 MFHAS1 EMILIN2 CYP46A1 ADCY3 FBXL21P PTPRB GNAZ FMNL1 SEMA3F SEMA4D ROR2 SLITRK4 LMTK2 NSUN7 SLC32A1 PRICKLE2 | 3.39e-05 | 504 | 280 | 17 | MM830 |
| Coexpression | GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP | CD109 DPP8 TTC7B POLR1B PLK1 NUP160 DNMT1 MICAL1 CCNF NADSYN1 | 3.54e-05 | 187 | 280 | 10 | M6807 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | RIPOR2 TSHZ2 CTSC NCAM1 BICD1 USH2A PLXNA2 DSCAM SLITRK4 LARP1B OPCML PTPRT CRMP1 SLC32A1 CELSR3 FRMD5 | 4.56e-05 | 465 | 280 | 16 | M39066 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | CTSC SPTAN1 BCOR ADCY3 INPP4B DMXL1 PTPRA PSME4 WASHC5 MICAL1 OGT NRDC LARP1 GLRX2 SPATA20 IDE IFI16 P4HA1 RMDN1 ASS1 UGGT2 CTTN | 4.58e-05 | 790 | 280 | 22 | M12490 |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_DN | 6.24e-05 | 200 | 280 | 10 | M8257 | |
| Coexpression | GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP | 6.24e-05 | 200 | 280 | 10 | M8625 | |
| Coexpression | GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN | 6.24e-05 | 200 | 280 | 10 | M7162 | |
| Coexpression | GSE23695_CD57_POS_VS_NEG_NK_CELL_DN | 6.24e-05 | 200 | 280 | 10 | M7786 | |
| Coexpression | GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_DN | BIRC6 PTPRA TTC12 PPP2R3C LY86 DNAH2 NUDT13 UBR7 LGALS3BP RAB40C | 6.24e-05 | 200 | 280 | 10 | M7814 |
| Coexpression | GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_DN | 7.47e-05 | 165 | 280 | 9 | M6685 | |
| Coexpression | ZHONG_PFC_C1_MICROGLIA | CCDC18 KIF4A PNPT1 NDC80 PLK1 PPP2R3C GLRX2 CCNF RMDN1 UHRF1 ABHD13 | 1.09e-04 | 257 | 280 | 11 | M39103 |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 1.22e-04 | 176 | 280 | 9 | M2981 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | CCDC18 INPP4B PTPN13 KIF15 NDC80 PLK1 DNAAF4 POLE ANKRD23 CEP152 EXOC4 | 1.01e-08 | 168 | 280 | 11 | a7eb28e15b591997f1aee09501cb20ae18beca08 |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIF4A KIF15 NDC80 PLCL2 PLK1 POLE LCAT CCNF LCTL CELSR3 UHRF1 | 2.33e-08 | 182 | 280 | 11 | bc6a120dedc813c58baac1428c39851a07b71ba7 |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | CTSC PTPN13 C3 ECEL1 PLXNA2 PLXNB1 MPP3 ARHGEF28 DSP LARP1B P4HA1 | 6.12e-08 | 200 | 280 | 11 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ARL11 CTSC EMILIN2 FMNL2 ADCY3 FMNL1 MICAL1 LIPA ZFYVE26 HCK | 1.63e-07 | 174 | 280 | 10 | d5c22b43531414951666ee7542a66ed9380e2d14 |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-07 | 181 | 280 | 10 | 74311aac2fe27dc02a9be3bc20e0c7ef1c239049 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-Proliferating_T_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.35e-07 | 181 | 280 | 10 | cf13bf7a531a2d40f8d778629cf2431b684f65f3 | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | RIPOR2 INPP4B DST NRDC OAS2 NBPF11 LGALS3BP NBPF1 NBPF10 SARAF | 2.48e-07 | 182 | 280 | 10 | 877b6e611626628e709568747512f2827ebb2795 |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-07 | 182 | 280 | 10 | 0fc45214f0b0766f69be6eff69cc4bec574023aa | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-07 | 187 | 280 | 10 | ed69e7cbd6fb59363b0e26f24887fc49405397ce | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.51e-07 | 189 | 280 | 10 | d049f33115610bda4489968759f754730698b9cd | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | MGAT4B PTGS2 GNAZ FMNL1 RILPL2 NBPF11 GUCY1B1 NBPF9 CTTN PROS1 | 4.26e-07 | 193 | 280 | 10 | add29b6abdfa49c7f0a0f49841a588d03e3bdb48 |
| ToppCell | CTRL-Myeloid-Alveolar_Macrophage|CTRL / Disease state, Lineage and Cell class | 4.47e-07 | 194 | 280 | 10 | be69b20afa915978c4cf2feb0bb21ab7c1f301a5 | |
| ToppCell | CTRL|World / Disease state, Lineage and Cell class | 4.68e-07 | 195 | 280 | 10 | cad77cdc6e0aa0875eff5ecd3805a6cf056d729d | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.75e-07 | 150 | 280 | 9 | 6e806a028c0519489151c181d9907e05289e27e0 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4|Liver / Manually curated celltypes from each tissue | TSHZ2 MFHAS1 SPTAN1 MGAT4A INPP4B PTPN13 GLS LGALS3BP CD3G SARAF | 5.14e-07 | 197 | 280 | 10 | 4891111894b741555f549deec6af8006376d9358 |
| ToppCell | Immune_cells-large_pre-B.|Immune_cells / Lineage and Cell class | 5.38e-07 | 198 | 280 | 10 | bc9ceefadb153907d2854d1f736d17349003cb31 | |
| ToppCell | CTRL-Myeloid|CTRL / Disease state, Lineage and Cell class | 5.64e-07 | 199 | 280 | 10 | 70b89a930709fdb91fde6f96106add8455b11618 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Mild / Disease, condition lineage and cell class | TSHZ2 MFHAS1 SPTAN1 INPP4B PNPT1 DST OAS2 LGALS3BP NBPF1 CD3G | 5.90e-07 | 200 | 280 | 10 | d9e8a0d047d4403fb7265fde7448e23a7780785c |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.07e-07 | 162 | 280 | 9 | 9d6931619f5eb847c79d00ff5ae031fef30fd55c | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-06 | 165 | 280 | 9 | 953c8242a81a39ade63ac8e5b34fe58575771746 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.17e-06 | 167 | 280 | 9 | 754e6412d3b9cc0b126e59593df2f5956b4712ef | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-06 | 169 | 280 | 9 | 54b13ab02b4c187f4754045ecfcf409749e7ccc0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-06 | 171 | 280 | 9 | 913bae728b5e653771a27c79a309eb023699f1d0 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-06 | 171 | 280 | 9 | f28b2336057e353b96a6ff4581ec9fd0ca0789d9 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.64e-06 | 174 | 280 | 9 | d77fa525d5c87c190b4a10787b270eabd16c610f | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.64e-06 | 174 | 280 | 9 | 6c36d607c48267a75ab4da6fb2fe3f931d1b3b52 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 178 | 280 | 9 | 15a99080e9f669572ab6d82934f324e6714846c1 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-06 | 178 | 280 | 9 | 200308e109abb7e6f8816a6f8cce6d56862d4098 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-06 | 184 | 280 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-06 | 184 | 280 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-06 | 184 | 280 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.72e-06 | 185 | 280 | 9 | 0e0f043ad6d2a62cd47ce39911ad81feab4a4d7e | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.72e-06 | 185 | 280 | 9 | 89b85ce8026dc80c1bd9f76dfe16401c173b7946 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-06 | 187 | 280 | 9 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.24e-06 | 189 | 280 | 9 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.24e-06 | 189 | 280 | 9 | 9ab77c6fcb573854da5922412f53d2168bda6b58 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.24e-06 | 189 | 280 | 9 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.39e-06 | 190 | 280 | 9 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-06 | 190 | 280 | 9 | b99271d139c8d01e20feb95d99f79c9b2756b4cb | |
| ToppCell | (02)_Cycling_Basal_(regeneration)|World / shred by cell type and Timepoint | 3.39e-06 | 190 | 280 | 9 | 53f017a11ca5ebe9025558e12cedc409cab2e5aa | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.39e-06 | 190 | 280 | 9 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.54e-06 | 191 | 280 | 9 | 9bb6a6b88f351217455765ba07a6acf11fda98f4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.69e-06 | 192 | 280 | 9 | 1c0ce299cee9ab5cdea256f3e8c1e5598577a8b6 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.85e-06 | 193 | 280 | 9 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | COVID_vent-Myeloid-Monocytic-CD16+_Monocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.01e-06 | 194 | 280 | 9 | b133d3d198360269cc449a75d34c29be377d91e0 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-CD16+_Monocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.01e-06 | 194 | 280 | 9 | ecf746ef1c5c4d6d9ca06a6d3e3778670b5700c2 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.01e-06 | 194 | 280 | 9 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | human_hepatoblastoma-NK.T_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 4.01e-06 | 194 | 280 | 9 | 997b02a22d7c89a8fd5615bb79a2a8a34fc3fee6 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.19e-06 | 195 | 280 | 9 | 67670d16ddd5d5ab7bc2254df329f5a7b2581556 | |
| ToppCell | cellseq-Immune-Immune_Myeloid-pMON-pMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.19e-06 | 195 | 280 | 9 | 2cb435dae2691e1250e26e59f9b8fb652a0c383e | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.19e-06 | 195 | 280 | 9 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | cellseq-Immune-Immune_Myeloid-pMON|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.19e-06 | 195 | 280 | 9 | 217908cb53016a6cb51f1bc3fc752c8df650df71 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 4.19e-06 | 195 | 280 | 9 | 578bbb06a5476c08fc3b351cc580c551dfe53ae4 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.19e-06 | 195 | 280 | 9 | 23dc2f8a3a038195a31feee7e3a51094a7a7c23e | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 4.19e-06 | 195 | 280 | 9 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.55e-06 | 197 | 280 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | TEKT3 KATNAL2 ODAD4 CFAP299 DNAH5 ALOX12B DNAAF4 DNAH2 HYDIN | 4.94e-06 | 199 | 280 | 9 | 15f7814b7074170eee7ccacaa670b1d128fc68bb |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.94e-06 | 199 | 280 | 9 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 5.14e-06 | 200 | 280 | 9 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 5.14e-06 | 200 | 280 | 9 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.14e-06 | 200 | 280 | 9 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.14e-06 | 200 | 280 | 9 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-E|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.14e-06 | 200 | 280 | 9 | ddfbc004e7bd2fd3f11f046ed8fc049277160547 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.14e-06 | 200 | 280 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | KATNAL2 ODAD4 CFAP299 DNAH5 ALOX12B DNAAF4 DNAH2 NSUN7 HYDIN | 5.14e-06 | 200 | 280 | 9 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f |
| ToppCell | 367C-Fibroblasts-Fibroblast-E-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.14e-06 | 200 | 280 | 9 | 57b9d6aa2265ab178a5886f36ecc66115bd382a8 | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 5.14e-06 | 200 | 280 | 9 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4|GI_large-bowel / Manually curated celltypes from each tissue | 5.14e-06 | 200 | 280 | 9 | 42403d59b65d4b3ba6aa4aaf2d7252176067fba5 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 5.14e-06 | 200 | 280 | 9 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 5.14e-06 | 200 | 280 | 9 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 5.14e-06 | 200 | 280 | 9 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Neuronal-Interneuron|1m / Sample Type, Dataset, Time_group, and Cell type. | SPTAN1 NCAM1 DST MPP3 ARHGAP23 SLITRK3 ANKRD23 CRMP1 SLC32A1 | 5.14e-06 | 200 | 280 | 9 | fc839e9c33ea1d4ee0f42f21fd32a54e7cbe1f5a |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.06e-06 | 154 | 280 | 8 | f78b01c19afcbab6319f61e4d6023ecb3d510d24 | |
| ToppCell | COVID-19_Severe-NK_CD56bright|World / disease group, cell group and cell class | 6.99e-06 | 157 | 280 | 8 | 9dcbabb377da7e93ec9f9abf09576a92877a7e02 | |
| ToppCell | AT1-AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.32e-06 | 158 | 280 | 8 | 3bc51cfd37b289cc3e866b54ce55a298e5eff690 | |
| ToppCell | TCGA-Mesothelium-Primary_Tumor-Mesothelioma-Biphasic-6|TCGA-Mesothelium / Sample_Type by Project: Shred V9 | 7.67e-06 | 159 | 280 | 8 | 85501c636cd04f15ba1be24df1ba7ac909633ce8 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tnaive/CM_CD4|Lung / Manually curated celltypes from each tissue | 8.79e-06 | 162 | 280 | 8 | 91cc14aec8d580cf97a1929bc1acb00fcbcdb57a | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.62e-06 | 164 | 280 | 8 | 249d8f75a64bce7db52ce0c563f496b9edf602a6 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.10e-05 | 167 | 280 | 8 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-05 | 168 | 280 | 8 | 2082b15fc7935a211f1c61506b305af5501a21ad | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Hematologic-leukocyte|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 168 | 280 | 8 | 5946204d42307391bc2160abe12850815f350aea | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-05 | 169 | 280 | 8 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-05 | 170 | 280 | 8 | 6b91d4cbe0697b65bfb2e099e7a9b39ea2fba3a9 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-05 | 171 | 280 | 8 | b113fbebb89056af0b9c775d2fb6552206a80467 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 171 | 280 | 8 | 55c7bf7211587fa08df13c0a4ff5b78a85d5439e | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-05 | 172 | 280 | 8 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.36e-05 | 172 | 280 | 8 | 282017db72d0537ac82aecc69393ccde9590be60 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.48e-05 | 174 | 280 | 8 | c988471207ba06195bc3e41056435e8c31c20bbe | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 174 | 280 | 8 | 7b318796728001c17b4043d2b033330c7be40c78 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_2|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.48e-05 | 174 | 280 | 8 | a75ba49ccea6bd3d78ada1092b46deb5202c58a5 | |
| ToppCell | Severe-B_intermediate-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.51e-05 | 126 | 280 | 7 | 42a0bdbe18ef85146cac4e86b2b27d0b3b20d8a2 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-05 | 175 | 280 | 8 | 7de1023161233b64f11e130881c742f4cf2bff65 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.54e-05 | 175 | 280 | 8 | 73f25bd54309aed1480ddc44bdab518b17e71f92 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.61e-05 | 176 | 280 | 8 | a84361308e5e96f3a30246cd29e109c321ee65bf | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 176 | 280 | 8 | 4f37854124d77ee64dcb40fd491eaed2ba389891 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 176 | 280 | 8 | d687e6c3f9043f2574d072f815b8c2258f9dc7b5 | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE-P5-P5_1-Sox4|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.61e-05 | 176 | 280 | 8 | d70fdc7bc48719776ed1e7c01118385e3a21623f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Myeloid-microglial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 176 | 280 | 8 | 0afba8707b847e5bdf6f38fe4379967631fe2240 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-05 | 177 | 280 | 8 | ac0cf03e2a1baf84db3ae245d59bbc6ae52c13be | |
| ToppCell | droplet-Fat-Bat-18m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 179 | 280 | 8 | e6224864eb76a2e9c1fc0c61513d9e936bb5c72c | |
| Disease | thalamus volume | 1.24e-05 | 85 | 267 | 7 | EFO_0006935 | |
| Disease | Neurodevelopmental Disorders | 2.24e-05 | 93 | 267 | 7 | C1535926 | |
| Disease | reticulocyte count | EPRS1 RAB11B ATR RAB11A ODAD4 ACTN1 BIRC6 ADCY3 KAT2B PTPRA CNTN5 GLS VPS13A LY86 DNMT1 SEMA3F CMKLR2 SEMA4D ARHGEF28 LARP1 SPATA20 CELF1 NT5C2 | 8.76e-05 | 1045 | 267 | 23 | EFO_0007986 |
| Disease | coronary artery disease | TDRD15 CD109 CHD2 CYP46A1 ABCA8 DMXL1 NFIB GLS SF3A3 MCF2L NUP160 ABCC10 FAT4 TTC41P DSCAM SLC35F1 LIPA CELSR2 GUCY1B1 KCTD10 NT5C2 UHRF1 KIF4B FBXO21 FGD6 | 9.47e-05 | 1194 | 267 | 25 | EFO_0001645 |
| Disease | citrullinemia (implicated_via_orthology) | 2.43e-04 | 3 | 267 | 2 | DOID:9273 (implicated_via_orthology) | |
| Disease | Seckel syndrome 1 | 2.43e-04 | 3 | 267 | 2 | C4551474 | |
| Disease | Bagassosis | 2.48e-04 | 14 | 267 | 3 | C0004681 | |
| Disease | Pneumoconiosis | 2.48e-04 | 14 | 267 | 3 | C0032273 | |
| Disease | Primary ciliary dyskinesia | 3.07e-04 | 36 | 267 | 4 | cv:C0008780 | |
| Disease | Ichthyosis Congenita I | 4.84e-04 | 4 | 267 | 2 | C4551630 | |
| Disease | Harlequin Fetus | 4.84e-04 | 4 | 267 | 2 | C0239849 | |
| Disease | Ichthyosis Congenita II | 4.84e-04 | 4 | 267 | 2 | C3536797 | |
| Disease | Collodion Fetus | 4.84e-04 | 4 | 267 | 2 | C3543867 | |
| Disease | glaucoma | 5.27e-04 | 154 | 267 | 7 | MONDO_0005041 | |
| Disease | diet measurement | TDRD15 KATNAL2 MFHAS1 NCAM1 CHD2 INPP4B PTPRA DST SERPINI2 ST8SIA6 CNTN5 DNAH5 CMKLR2 SEMA4D RILPL2 DSCAM RAB11FIP2 PTPRT CELSR2 CELF1 EXOC4 | 6.20e-04 | 1049 | 267 | 21 | EFO_0008111 |
| Disease | hydrocephalus (implicated_via_orthology) | 6.38e-04 | 19 | 267 | 3 | DOID:10908 (implicated_via_orthology) | |
| Disease | Congenital ichthyosis | 8.01e-04 | 5 | 267 | 2 | C0020758 | |
| Disease | immunoglobulin superfamily DCC subclass member 4 measurement | 8.01e-04 | 5 | 267 | 2 | EFO_0801690 | |
| Disease | Intellectual Disability | RAB11B RAB11A KIF4A FCSK PNPT1 NFIB RHOBTB2 UBR7 PRKRA ASS1 NT5C2 AP4M1 | 8.40e-04 | 447 | 267 | 12 | C3714756 |
| Disease | Primary Ciliary Dyskinesia | 8.61e-04 | 47 | 267 | 4 | C4551720 | |
| Disease | Cystic kidney | 1.19e-03 | 6 | 267 | 2 | C0022679 | |
| Disease | Global developmental delay | 1.37e-03 | 133 | 267 | 6 | C0557874 | |
| Disease | inflammatory bowel disease (implicated_via_orthology) | 1.45e-03 | 25 | 267 | 3 | DOID:0050589 (implicated_via_orthology) | |
| Disease | cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement | 1.75e-03 | 243 | 267 | 8 | EFO_0004612, EFO_0020944 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.87e-03 | 303 | 267 | 9 | EFO_0004612, EFO_0020945 | |
| Disease | FEV/FEC ratio | CDH23 NCAM1 ADCY3 INPP4B PTPN4 WWC2 DST TTC7B KIF15 CNTN5 MICAL3 DNAH5 LY86 ARAP2 ARHGEF28 DSP UGGT2 SSH2 CTTN LRRC37B FGD6 HDLBP | 1.92e-03 | 1228 | 267 | 22 | EFO_0004713 |
| Disease | Liver Cirrhosis, Experimental | AADAC ARL11 SPTAN1 ACTN1 PTER PTGS2 OLFML3 GLS LY86 FMNL1 FMO1 RBL2 ANXA5 GPT HCK SEZ6 | 1.98e-03 | 774 | 267 | 16 | C0023893 |
| Disease | pulse pressure measurement | TDRD15 MFHAS1 NCAM1 CHD2 RYK FCSK PNPT1 KIF15 PLEKHM2 SF3A3 MCF2L NUP160 ABCC10 DNMT1 SLC4A7 RILPL2 DSCAM POLR2L CELF1 NT5C2 CDYL2 UHRF1 FGD6 HYDIN | 2.00e-03 | 1392 | 267 | 24 | EFO_0005763 |
| Disease | hearing impairment | 2.00e-03 | 98 | 267 | 5 | C1384666 | |
| Disease | health study participation | 2.07e-03 | 195 | 267 | 7 | EFO_0010130 | |
| Disease | smoking status measurement | TSHZ2 NCAM1 BIRC6 ADCY3 INPP4B CNTN5 PLCL2 USH2A UNC79 PLXNA2 ARAP2 MPP3 SEMA3F LMTK2 GRIK1 OPCML NT5C2 PRICKLE2 UHRF1 EXOC4 SEZ6 | 2.14e-03 | 1160 | 267 | 21 | EFO_0006527 |
| Disease | memory impairment | 2.20e-03 | 8 | 267 | 2 | EFO_0001072 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 2.20e-03 | 8 | 267 | 2 | EFO_0008589, EFO_0008595 | |
| Disease | endometrial cancer (implicated_via_orthology) | 2.20e-03 | 8 | 267 | 2 | DOID:1380 (implicated_via_orthology) | |
| Disease | alcohol consumption measurement | TSHZ2 IFT172 NCAM1 ACTN1 FMNL2 BIRC6 INPP4B PTPRB PLEKHM2 TTC12 MICAL3 DNAH5 NUP160 PLXNA2 ARAP2 IMPG2 MPP3 SEMA3F DNAH2 OPCML CELF1 FRMD5 | 2.21e-03 | 1242 | 267 | 22 | EFO_0007878 |
| Disease | Liver carcinoma | KIF4A PTGS2 INPP4B PNPT1 KIF15 NDC80 GNAZ PLK1 LCAT CCNF CELSR3 UHRF1 | 2.41e-03 | 507 | 267 | 12 | C2239176 |
| Disease | post-traumatic stress disorder | 2.53e-03 | 202 | 267 | 7 | EFO_0001358 | |
| Disease | lung cancer (implicated_via_orthology) | 2.82e-03 | 9 | 267 | 2 | DOID:1324 (implicated_via_orthology) | |
| Disease | Nephronophthisis | 2.82e-03 | 9 | 267 | 2 | cv:C0687120 | |
| Disease | isovalerate measurement | 2.82e-03 | 9 | 267 | 2 | EFO_0021051 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.92e-03 | 264 | 267 | 8 | EFO_0008317, EFO_0020944 | |
| Disease | intestinal cancer (implicated_via_orthology) | 2.99e-03 | 32 | 267 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | Large cell carcinoma of lung | 2.99e-03 | 32 | 267 | 3 | C0345958 | |
| Disease | Squamous cell carcinoma of lung | 2.99e-03 | 32 | 267 | 3 | C0149782 | |
| Disease | prostate cancer (implicated_via_orthology) | 3.27e-03 | 33 | 267 | 3 | DOID:10283 (implicated_via_orthology) | |
| Disease | carbamazepine-induced hyponatremia, response to oxcarbazepine, oxcarbazepine-induced hyponatremia, response to carbamazepine | 3.50e-03 | 10 | 267 | 2 | EFO_0008484, EFO_0009893, EFO_0009894, EFO_0009895 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 3.50e-03 | 10 | 267 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | plasma trimethylamine N-oxide measurement | 3.50e-03 | 10 | 267 | 2 | EFO_0005691 | |
| Disease | reticulocyte measurement | RAB11B ATR RAB11A BIRC6 ADCY3 KAT2B PTPRA CNTN5 GLS VPS13A LY86 DNMT1 SEMA3F CMKLR2 SEMA4D ARHGEF28 LARP1 CELF1 NT5C2 | 3.57e-03 | 1053 | 267 | 19 | EFO_0010700 |
| Disease | susceptibility to mononucleosis measurement | 3.57e-03 | 69 | 267 | 4 | EFO_0008403 | |
| Disease | Kartagener Syndrome | 3.87e-03 | 35 | 267 | 3 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 3.87e-03 | 35 | 267 | 3 | C4551906 | |
| Disease | triacylglycerol 58:8 measurement | 3.87e-03 | 35 | 267 | 3 | EFO_0010442 | |
| Disease | Polynesian Bronchiectasis | 3.87e-03 | 35 | 267 | 3 | C4317124 | |
| Disease | Adenocarcinoma | 4.15e-03 | 116 | 267 | 5 | C0001418 | |
| Disease | Carcinoma, Granular Cell | 4.15e-03 | 116 | 267 | 5 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 4.15e-03 | 116 | 267 | 5 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 4.15e-03 | 116 | 267 | 5 | C0205642 | |
| Disease | Carcinoma, Cribriform | 4.15e-03 | 116 | 267 | 5 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 4.15e-03 | 116 | 267 | 5 | C0205641 | |
| Disease | cholesteryl esters to total lipids in very large HDL percentage | 4.20e-03 | 36 | 267 | 3 | EFO_0022257 | |
| Disease | Congenital Nonbullous Ichthyosiform Erythroderma | 4.25e-03 | 11 | 267 | 2 | C0079154 | |
| Disease | Cognitive impairment | 4.25e-03 | 11 | 267 | 2 | HP_0100543 | |
| Disease | Congenital ichthyosis of skin | 4.25e-03 | 11 | 267 | 2 | cv:C0020758 | |
| Disease | Cystic Kidney Diseases | 4.25e-03 | 11 | 267 | 2 | C1691228 | |
| Disease | chronic obstructive pulmonary disease | MFHAS1 CNTN5 SF3A3 MICAL3 DNAH5 LY86 ARAP2 ARHGEF28 DSP SSH2 CTTN LRRC37B FGD6 HDLBP | 4.26e-03 | 688 | 267 | 14 | EFO_0000341 |
| Disease | Mood Disorders | 4.38e-03 | 168 | 267 | 6 | C0525045 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 4.54e-03 | 37 | 267 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | grip strength measurement | 4.84e-03 | 350 | 267 | 9 | EFO_0006941 | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 5.07e-03 | 12 | 267 | 2 | EFO_0801493 | |
| Disease | Methionine sulfoxide measurement | 5.07e-03 | 12 | 267 | 2 | EFO_0021650 | |
| Disease | response to diuretic, high density lipoprotein cholesterol measurement | 5.07e-03 | 12 | 267 | 2 | EFO_0004612, GO_0036270 | |
| Disease | granulins measurement | 5.07e-03 | 12 | 267 | 2 | EFO_0008141 | |
| Disease | aspirin use measurement | 5.26e-03 | 39 | 267 | 3 | EFO_0007013 | |
| Disease | deoxycholate measurement | 5.26e-03 | 39 | 267 | 3 | EFO_0010475 | |
| Disease | Hypercholesterolemia | 5.26e-03 | 39 | 267 | 3 | C0020443 | |
| Disease | amyloid-beta measurement | 5.30e-03 | 355 | 267 | 9 | EFO_0005194 | |
| Disease | Inherited neuropathies | 5.65e-03 | 40 | 267 | 3 | C0598589 | |
| Disease | obsolete_red blood cell distribution width | ATR CDH23 BIRC6 INPP4B PTPRA ST8SIA6 CNTN5 PLCL2 VPS13A SF3A3 MPP3 OGT ARHGAP23 LARP1 MON1A CCNF LIPA LOXHD1 KCTD10 NT5C2 LRRC37B FRMD5 | 5.73e-03 | 1347 | 267 | 22 | EFO_0005192 |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 5.96e-03 | 13 | 267 | 2 | C1846647 | |
| Disease | Bardet-Biedl Syndrome | 5.96e-03 | 13 | 267 | 2 | C0752166 | |
| Disease | kidney disease (implicated_via_orthology) | 6.06e-03 | 41 | 267 | 3 | DOID:557 (implicated_via_orthology) | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 6.21e-03 | 364 | 267 | 9 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | Malignant neoplasm of stomach | 6.25e-03 | 300 | 267 | 8 | C0024623 | |
| Disease | mood instability measurement | 6.27e-03 | 128 | 267 | 5 | EFO_0008475 | |
| Disease | Malignant Neoplasms | 6.27e-03 | 128 | 267 | 5 | C0006826 | |
| Disease | otosclerosis | 6.32e-03 | 81 | 267 | 4 | EFO_0004213 | |
| Disease | mean reticulocyte volume | RIPOR2 ATR NEXMIF DPP8 KAT2B PTPRA CNTN5 PLCL2 VPS13A PLK1 LY86 ABCC10 DNAH2 HPS3 HDLBP | 6.50e-03 | 799 | 267 | 15 | EFO_0010701 |
| Disease | polyunsaturated fatty acid measurement | 6.90e-03 | 131 | 267 | 5 | EFO_0010733 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 6.91e-03 | 14 | 267 | 2 | EFO_0004611, EFO_0008589 | |
| Disease | glucose-dependent insulinotropic peptide measurement, glucose tolerance test | 6.91e-03 | 14 | 267 | 2 | EFO_0004307, EFO_0008464 | |
| Disease | wet macular degeneration | 6.91e-03 | 14 | 267 | 2 | EFO_0004683 | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 6.91e-03 | 14 | 267 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | Proteinuria | 6.92e-03 | 43 | 267 | 3 | C0033687 | |
| Disease | ovarian neoplasm | 7.58e-03 | 134 | 267 | 5 | C0919267 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 7.79e-03 | 86 | 267 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | eye disease | 7.86e-03 | 45 | 267 | 3 | EFO_0003966 | |
| Disease | response to statin, LDL cholesterol change measurement | 7.92e-03 | 15 | 267 | 2 | EFO_0007804, GO_0036273 | |
| Disease | Situs ambiguus | 7.92e-03 | 15 | 267 | 2 | C0266642 | |
| Disease | Hypertriglyceridemia | 7.92e-03 | 15 | 267 | 2 | C0020557 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SEEGLYLDSEAVLDY | 161 | Q7L211 | |
| LAELGAVQVDYYLDE | 196 | P24298 | |
| DTYLVYILNELAGNS | 251 | Q9H0S4 | |
| EELLAEAKYYLVQGL | 106 | Q9H3F6 | |
| ANADGYSLYDVEISI | 181 | Q6UXE8 | |
| QLEIYQYEEDILTVL | 1036 | O94986 | |
| VKVYDYQEDGSVLLT | 31 | P09693 | |
| EKLLETIDQLYLEYA | 501 | P12814 | |
| ENQEYLIDKYLTDGG | 121 | Q86SG2 | |
| YFVLLNYVKDEDLAG | 1451 | Q9NR09 | |
| LTLKQQYDELEAEYD | 46 | Q96G01 | |
| YEVDINGLEILECKY | 406 | Q96G01 | |
| YFLYALDDGTIQIQD | 551 | Q5SY80 | |
| LEQLEDLDSRVLYYS | 911 | P26358 | |
| VFDTLYGNLLKVDAY | 101 | P49902 | |
| YVITCQYDLLRDDGL | 336 | P22760 | |
| DLRELFEQYGAVYEI | 31 | Q92879 | |
| AYLKEDIGGELVYVL | 1606 | Q86UK0 | |
| IDLFLYVVGSSYENE | 106 | Q9P299 | |
| DLFALDLELYRYSGV | 261 | P39086 | |
| LDREQGACLYLVDVY | 1696 | Q6V0I7 | |
| TLYDVILYGLQEHSE | 106 | Q5T440 | |
| LANGVDRYISKYELD | 1421 | P01024 | |
| DDDLNTIEFKILAYY | 16 | Q9BZR8 | |
| TEADYDLIGQLFYKD | 1011 | Q8WZ64 | |
| LLDEYELSIYDLNGD | 61 | Q5H913 | |
| AELDYEDQVSYTLAI | 771 | Q9HCU4 | |
| LALGENDKALYYFLE | 1076 | Q96PN6 | |
| ELRAIKQVYEEEYGS | 121 | P08758 | |
| ARLGYEEVVLYCLEN | 1471 | Q6W2J9 | |
| LALDADQDIYAVVTY | 1986 | Q9H251 | |
| DGQYLRLYEAVIDAK | 766 | Q9Y485 | |
| AIQSSALYEDRYLLG | 76 | P00966 | |
| ELLDEVLDYGYVQTT | 111 | O00189 | |
| EIDLESDYRYSLIDG | 141 | O94779 | |
| DEYDYLFKVVLIGDS | 6 | P62491 | |
| DEYDYLFKVVLIGDS | 6 | Q15907 | |
| YDYLLKFLLVGDSDV | 11 | Q96S21 | |
| LDLFLAYYVQEQDSG | 176 | O00712 | |
| SLEQIYGLENSKEYL | 71 | O75943 | |
| YGLTADTYIDLAADE | 266 | Q9NRN5 | |
| YDATRVILKGNEDYI | 691 | P29074 | |
| LKYAIAVNDLGTEYV | 291 | O94925 | |
| LKNYEIIFYLAGSEV | 406 | O95907 | |
| GYLRESDLENYILEL | 186 | Q969Q6 | |
| KAYEEYVLSVGNLDE | 336 | Q08999 | |
| GLEDLFYKYGVDLQL | 316 | Q6ZNF0 | |
| AYLEEKLHIYAELGE | 1231 | Q8N1W1 | |
| DYLEGTDILVYVLDS | 76 | Q969Q4 | |
| EYYLAKQALAENEVL | 886 | Q6IWH7 | |
| LVDYILGTYQAIDED | 401 | P32926 | |
| AEGATLDIFDYIYID | 336 | O94952 | |
| LYIEDSYVLEGDKQL | 41 | Q9UBM8 | |
| EKGIYYIQLEDDIIV | 251 | Q9UM21 | |
| YQEKELYLLDDPLAA | 741 | Q5T3U5 | |
| YEAIKEGVNIRYLDL | 331 | Q8WUM0 | |
| AKVINDGLFYYEQDL | 676 | Q6PKG0 | |
| QADSNYLLSKEYEEL | 1696 | P23467 | |
| ATGIDLENIVYYKDD | 281 | Q7RTP6 | |
| REVYEQLYDTLDITG | 51 | Q9HAP6 | |
| ILSIDYALDYELSSG | 86 | P04201 | |
| FIEIYNEQIYDLLDS | 166 | Q9NS87 | |
| LEADYYDLQLQLYEV | 526 | Q8N9B5 | |
| LDLYAYAVATGDALL | 261 | Q08380 | |
| LKELYTLLNENYVED | 171 | O60551 | |
| GEYQVLLELYTEKRS | 136 | O95711 | |
| DYVYEALLNTDIDID | 111 | P46199 | |
| LRFIVYDLAGDESYE | 471 | Q9Y4C4 | |
| DILNFLTYADEYAIG | 601 | Q92831 | |
| AQSKGIYYVQLEDDI | 256 | Q9UQ53 | |
| IDVQILIDGKYYQAD | 446 | Q03001 | |
| RYVDLDGFDALLTDY | 56 | Q8WXJ9 | |
| LIVQYEGLLSTYSDE | 661 | O15327 | |
| LDDLYGRYLEIKEIS | 1256 | Q8IYD8 | |
| GRYLEIKEISDANYV | 1261 | Q8IYD8 | |
| LALYEAELLNYASED | 16 | Q8IVV2 | |
| EYIKAEELYIGVTVN | 501 | Q5JST6 | |
| YVSKYSEELIGALEQ | 1856 | O75051 | |
| NKYYDQIITALEEDG | 2096 | O43157 | |
| LDTDYEGYAILRVSL | 106 | Q6JVE9 | |
| ACDGYYKVQEDIILL | 86 | Q6UWM7 | |
| YGEVIDLSNYEELTD | 56 | Q9UBM4 | |
| YYKLVTDGALDREEI | 401 | Q9Y5G2 | |
| YLTQEGYIDTANALE | 36 | Q8IYT4 | |
| DVAGNLDYKALSYVI | 151 | Q02045 | |
| LYKNLELTNYLEDIE | 671 | O00408 | |
| TGKNDNYSVEDLLYI | 231 | Q6UXP7 | |
| VEIQDLELATGYKVY | 191 | Q6UWB1 | |
| AVYLVYDQELLGPSD | 21 | Q5XKP0 | |
| LQLELRLGYDDYVQV | 296 | O75074 | |
| ELEALYGDIDAVELY | 476 | P35354 | |
| KDSFEGLLYLQYLDL | 596 | Q96QE4 | |
| YYIQLEEKSGSNLEL | 551 | Q8IWU2 | |
| ATGIDLENIVYYKDD | 276 | Q8TDZ2 | |
| LILHYYSEREGLQDI | 131 | Q02153 | |
| ILDEDKRLGSAVDYY | 71 | Q07864 | |
| EAVDCVYSLLYLQLG | 986 | Q8NDA8 | |
| EVYAGLIDLYKSSDL | 501 | P29728 | |
| QYAYTGRLELKEDNI | 276 | Q96PQ7 | |
| KAYRDGLVEQLYDLT | 516 | Q9Y3T9 | |
| GLVEQLYDLTLEYLH | 521 | Q9Y3T9 | |
| VYSLEEQYLGLALDV | 1006 | Q3BBV0 | |
| VAEEVGLEVESLQYY | 246 | Q86X67 | |
| YLAQDEDSEKILAAY | 276 | O95672 | |
| QEYEIAEELYTKGDR | 926 | Q9UG01 | |
| LLEFAQLGCYLEYDL | 241 | Q96BW5 | |
| LEYDLFGTELLHYQL | 251 | Q96BW5 | |
| ITLYEINYKAVGSLD | 516 | O14522 | |
| DLKPENLLYYSLDED | 141 | Q14012 | |
| YLEISDIKRDQSGEY | 186 | Q14982 | |
| LSYAVYQQGDLDKAL | 211 | P13674 | |
| NELLVDLIYFYQDGK | 166 | Q7Z3G6 | |
| NIVNYLDSYLVGDEL | 326 | Q13153 | |
| SEEEQERLLGLYQYL | 566 | Q86VX9 | |
| LVLDIYYQGTEAEIQ | 196 | Q8N0W3 | |
| LAAYILQAEIGDYDS | 136 | Q7Z6J6 | |
| LENYIEVETGYLKSR | 346 | O00471 | |
| NLVVDQGVKYTELEY | 911 | Q96A65 | |
| EVDAEYLLGPLYAAL | 386 | Q13535 | |
| LTDANLTKDYIDGVY | 641 | Q6YHK3 | |
| AGSEDIIVVALYDYE | 76 | P08631 | |
| YEAILYNKGSIDALF | 481 | Q4G0P3 | |
| VELSGYDLKLYEDNQ | 226 | P19086 | |
| ITYIKDGQRYEELDD | 191 | Q9BX69 | |
| EAAVKLGIAYLYNEG | 101 | P41002 | |
| YLDFEDLGRLQYLSQ | 341 | Q9Y6A2 | |
| YNEATLYKDVRDLLA | 266 | Q9H8Y5 | |
| YIATQYKEAIDLGQE | 1121 | Q5T9S5 | |
| YLGGENLELRDYQLE | 476 | O14647 | |
| IALYEKDNTYLVELS | 101 | Q96JB5 | |
| KALQSDYITYIDELL | 426 | Q01740 | |
| VEGLQYLASRYDFID | 731 | Q6V1X1 | |
| SAIYQLEEEYENLLK | 246 | P15924 | |
| AYKRGYFNEELSEIL | 2391 | P15924 | |
| NVNYKVVELDLLEYG | 91 | Q9NS18 | |
| VYLQKLDTAYDDLGN | 66 | P53634 | |
| YLEEKGIETYLIIAS | 481 | O60266 | |
| RYYSLDELSEKGIED | 291 | Q9BRF8 | |
| KGLDVLVEYLSFAQY | 131 | Q96PY5 | |
| AELEKGNIYLADYRI | 306 | O75342 | |
| ISDYLEYDSLLEVNE | 261 | Q16666 | |
| YLYSSGLLQDREAKE | 56 | Q68D91 | |
| YVEELLCVLEGYAAE | 646 | O15068 | |
| LQYEFTHLGLDLYLE | 346 | O95466 | |
| LYVEGLQDYEAALKI | 381 | Q8WXU2 | |
| NYVDYLDELALEIGA | 431 | Q99518 | |
| LKVSYLEIYNEEILD | 136 | O95239 | |
| LKVSYLEIYNEEILD | 136 | Q2VIQ3 | |
| YLYEAEEATTLQGLA | 551 | A4D0S4 | |
| ALQAYIDDFDLGQIY | 51 | Q8IYD9 | |
| QQEEYYRKLAGLVEE | 176 | P04180 | |
| DGSYNIRKDDIIALY | 376 | P22680 | |
| AELAGLSYDLQNTIY | 611 | P14735 | |
| NELYQAYVDSKIDAL | 311 | Q9BXX0 | |
| ALDYGADIVYCEELI | 31 | Q9NX74 | |
| GTVLLIEEDKYNIYS | 81 | Q96EB1 | |
| ALIDLDYEARQEYVI | 1126 | Q9NYQ7 | |
| YYEDLLGDQAFLSQL | 86 | Q15125 | |
| ELSEQLYDVGYRDIV | 61 | Q8N6R0 | |
| LVSVDEESYGALYQA | 171 | Q8TB52 | |
| YDYDVQDTTLDGLLI | 301 | Q8IX18 | |
| VSENLLSLYLDEYEE | 4016 | Q9P225 | |
| LIGLDAELYYVRNDL | 76 | P34925 | |
| NYYLDEFANLLDELL | 2786 | Q8TDX9 | |
| LYADVYLEDGLIKQI | 31 | Q14194 | |
| LTAEDVYDISYLLGR | 36 | Q969X0 | |
| DDKYQLILENYGADI | 586 | Q8TE73 | |
| ITSELAKVINDGLYY | 476 | Q659C4 | |
| ENLELTYGYLLEEDV | 296 | Q5VWM6 | |
| LLASLALQAEYGDYQ | 701 | Q12923 | |
| QALLEHYLYGDTELE | 496 | P18433 | |
| ACVYYEQGLIDLAID | 266 | O15294 | |
| YEDIAVKLGTDLEYL | 976 | O15294 | |
| ELYALGSIHNDLYVI | 376 | Q3ZCT8 | |
| DLNDQVTLLKYGVYE | 301 | Q07869 | |
| EAVSYNELDYVSVGL | 651 | Q8IWE5 | |
| EYKENLYGTSLEAIQ | 456 | Q13368 | |
| LYYGNEATLLIFDLL | 931 | Q5HYA8 | |
| GLRELALNYYILTDE | 231 | Q9UKT6 | |
| INLLLSYRDIQDYDA | 286 | Q6ZN16 | |
| LREEEIDDIGYALYS | 431 | Q96C03 | |
| ELDGLEKYTNYSIQV | 1151 | O60469 | |
| TFLGIENLEYLQADY | 126 | Q8IW52 | |
| LIYSGSEENYIVTDL | 2096 | O75445 | |
| SEIIGYALDTLYNII | 76 | O60763 | |
| YEYFAVLAAKELGIS | 91 | P82664 | |
| VLQILDLYAQVYEEL | 1186 | P07814 | |
| YPGLQALDEEYLKVD | 166 | P54577 | |
| IYEALEKLFDLGETY | 736 | Q9Y6M7 | |
| FIDYGNYEEVLLSNI | 591 | Q9H7E2 | |
| SALINEELYAGVYID | 211 | Q13275 | |
| GIELYDGSQYINEKI | 1121 | B5MCY1 | |
| GLEYNLDYTELGLQK | 131 | Q96BY9 | |
| KGLLLYYDLVESTFE | 371 | P04053 | |
| RLAYSEAGDYLVAIE | 66 | Q969F9 | |
| YSLEEQYLGLALDVD | 701 | Q3BBV2 | |
| YSLEEQYLGLALDLD | 736 | P0DPF3 | |
| YSLEEQYLGLALDVD | 736 | Q6P3W6 | |
| SAVYSLEEQYLGLAL | 1221 | Q6P3W6 | |
| AVYSLEEQYLGLALD | 1466 | Q6P3W6 | |
| VYSLEEQYLGLALDV | 1711 | Q6P3W6 | |
| YSLEEQYLGLALDVD | 1956 | Q6P3W6 | |
| SAVYSLEEQYLGLAL | 2441 | Q6P3W6 | |
| AVYSLEEQYLGLALD | 2686 | Q6P3W6 | |
| VYSLEEQYLGLALDV | 2931 | Q6P3W6 | |
| YSLEEQYLGLALDVD | 3176 | Q6P3W6 | |
| SAVYSLEEQYLGLAL | 3661 | Q6P3W6 | |
| YSLEEQYLGLALDVD | 736 | Q86T75 | |
| VYSLEEQYLGLALDV | 1006 | Q5TAG4 | |
| YSLEEQYLGLALDVD | 1251 | Q5TAG4 | |
| YSLEEQYLGLALDVD | 396 | Q5TI25 | |
| SAVYSLEEQYLGLAL | 706 | A0A087WUL8 | |
| AVYSLEEQYLGLALD | 951 | A0A087WUL8 | |
| VYSLEEQYLGLALDV | 1196 | A0A087WUL8 | |
| YSLEEQYLGLALDVD | 1441 | A0A087WUL8 | |
| SAVYSLEEQYLGLAL | 1926 | A0A087WUL8 | |
| AVYSLEEQYLGLALD | 2171 | A0A087WUL8 | |
| VYSLEEQYLGLALDV | 2416 | A0A087WUL8 | |
| YSLEEQYLGLALDVD | 2661 | A0A087WUL8 | |
| SAVYSLEEQYLGLAL | 3146 | A0A087WUL8 | |
| AVYSLEEQYLGLALD | 3391 | A0A087WUL8 | |
| VYSLEEQYLGLALDV | 3636 | A0A087WUL8 | |
| YSLEEQYLGLALDVD | 121 | P0DPF2 | |
| SAVYSLEEQYLGLAL | 606 | P0DPF2 | |
| AVYSLEEQYLGLALD | 851 | P0DPF2 | |
| VYSLEEQYLGLALDV | 1096 | P0DPF2 | |
| YSLEEQYLGLALDVD | 1341 | P0DPF2 | |
| SAVYSLEEQYLGLAL | 1826 | P0DPF2 | |
| AVYSLEEQYLGLALD | 2071 | P0DPF2 | |
| VYSLEEQYLGLALDV | 2316 | P0DPF2 | |
| YSLEEQYLGLALDVD | 2561 | P0DPF2 | |
| SAVYSLEEQYLGLAL | 3046 | P0DPF2 | |
| AVYSLEEQYLGLALD | 3291 | P0DPF2 | |
| VYSLEEQYLGLALDV | 3536 | P0DPF2 | |
| YSLEEQYLGLALDVD | 3781 | P0DPF2 | |
| SAVYSLEEQYLGLAL | 4266 | P0DPF2 | |
| AVYSLEEQYLGLALD | 4436 | P0DPF2 | |
| VYSLEEQYLGLALDV | 4606 | P0DPF2 | |
| VYSLEEQYLGLALDV | 4756 | P0DPF2 | |
| YSLEEQYLGLALDVD | 5001 | P0DPF2 | |
| YSLEEQYLGLALDVD | 696 | B4DH59 | |
| DLEDPAQKSYYEALL | 226 | Q5QGS0 | |
| DYLYDVDSLEGEKVN | 491 | Q5QGS0 | |
| YELAFSALKYQDILE | 91 | Q8NE18 | |
| TVRQLLGELYVDKEY | 186 | Q96NG3 | |
| IYGENYESLDLVANS | 221 | Q9UPR0 | |
| LGLESLEYLQADYNV | 146 | O94933 | |
| KYLYTGELDENERDL | 431 | Q9BYZ6 | |
| KGYSENDYLQIITDI | 96 | P61647 | |
| IKGEYALAAELYREV | 1036 | Q149N8 | |
| DILANYLSEESLADY | 1561 | Q13796 | |
| DLIFQKDYLEYGEIL | 191 | Q7Z7L1 | |
| EYDLAVKANSLYIDQ | 456 | Q9BXF9 | |
| ISDLGLFREVYAADY | 631 | Q01974 | |
| DIYNYSALLLSEDKD | 46 | Q92854 | |
| QDISLELDRIGTDYY | 836 | Q9BZV3 | |
| YILLGLADVEANYVI | 111 | Q8IXU6 | |
| DYRLLTDILGIEDYN | 526 | Q8TCS8 | |
| YLNYDLLEEAVDLVS | 1341 | Q12769 | |
| KYELLYLAEQFAGVV | 296 | P07225 | |
| TYDSEGVILYAESID | 331 | P07225 | |
| EALVLYDRVLKYANE | 481 | Q9UHB9 | |
| EVYRALKNGLDEYLE | 76 | Q9Y4F9 | |
| LYKDLDSYPDLGIEN | 761 | O94911 | |
| DLALEYYVLGESFET | 516 | O00116 | |
| GLDSLFSYLQDKIYE | 491 | Q8N8U2 | |
| VDLYYLEDETLARQL | 31 | Q6V702 | |
| LEIDILYQLADLYNA | 266 | O75746 | |
| YYSLESDLEEKVQLG | 21 | P46091 | |
| ETYDQADVIVADLYL | 96 | Q9Y6N3 | |
| LTIYNANIDDAGIYK | 81 | P13591 | |
| ALGENYELLIYEFNL | 106 | Q96JI7 | |
| LTNNLDKVGIYLDYE | 436 | Q86WT6 | |
| GLIDLEANYLVVKAY | 136 | Q5T1Q4 | |
| YTLFDYDVGLNDIIQ | 56 | Q96PU4 | |
| LDLRQYLGNSTYLDD | 76 | Q9Y2C2 | |
| IQEAEEYLSGELYKD | 506 | Q9P2K2 | |
| LSLDEVYLIDSGAQY | 406 | Q9NQW7 | |
| DNTLLYEITAYLEAA | 1006 | Q12768 | |
| ALALDEYVRLNDAYK | 126 | Q6AWC2 | |
| DQIDVDYQYKLDFLL | 476 | Q6AWC2 | |
| EEKALLYEAIGYSET | 461 | Q96RL7 | |
| TYEYTRGELLVLDLQ | 1911 | Q9BX84 | |
| NIRVYDEEATDLLAY | 356 | Q76I76 | |
| ILEQADYLYESGETE | 86 | Q96DB5 | |
| YDEYENDLGITAVAL | 486 | Q14247 | |
| NDLGITAVALYDYQA | 491 | Q14247 | |
| YDKIIEERDSELGLY | 721 | Q15431 | |
| EDILQLAYSQDAYLK | 156 | Q9P227 | |
| DYAFVVRGLLDLYEA | 576 | Q8TB22 | |
| ETGKELVLALYDYQE | 966 | Q13813 | |
| SLYKDVDYGTEVLQI | 306 | Q7Z6K1 | |
| LTDYLKNLIEDAGDY | 1026 | Q6ZV73 | |
| YYEGLQDKLAQIRDA | 466 | O14964 | |
| GDVDQDGYLLLKSVY | 131 | Q6ZS81 | |
| EAGYDVSEAYLLSVA | 771 | Q6P2S7 | |
| YEADVAQLEYKLVAG | 741 | O43847 | |
| SIYAREALIEIDYGD | 971 | Q14683 | |
| DSYEVEYLPIEGLLS | 486 | Q53EL9 | |
| SLNYQVLELSYKGDE | 231 | O75830 | |
| LLGYDISEKLYTLND | 236 | Q9HBU9 | |
| VYLTALDTNGDYIAV | 36 | O15040 | |
| AGYRSLTYEEVLQEL | 446 | Q7L804 | |
| LAVAAGLYYLAELIE | 21 | Q6UWH6 | |
| YLGLLQAEYTEGDAL | 21 | P62875 | |
| NLIIDEYYDNTGRIL | 311 | O43548 | |
| LEETKLYTGLEYDLS | 846 | Q14997 | |
| IKYQYLREEDLEDGS | 496 | Q9NRE2 | |
| ITYLDIDELSANGQY | 256 | O75569 | |
| VKDLGLVENYISFYD | 1696 | Q9P2E3 | |
| ELGLYKVNEYVDARD | 131 | Q96T88 | |
| GEYEAALTIYDTHIL | 266 | Q5R3I4 | |
| YEKAGDIALLYLQEI | 176 | Q86TV6 | |
| QKLLQEDLAYDYDLI | 146 | Q86VQ6 | |
| LTDEYDTVLAYENKG | 331 | Q8N806 | |
| NYETAILRYSEGLEK | 121 | Q9H892 | |
| AFLEAQIYEYVEILG | 321 | Q12874 | |
| YAKDDYELIDVLVNN | 1531 | Q6PGP7 | |
| YTGKILIACLYEENE | 161 | Q9H598 | |
| EYLADVVDSEALQVY | 1196 | Q00341 | |
| VTAEYELEYLLLEGQ | 1081 | Q9NYU1 | |
| LELEADIFIGVVYYQ | 986 | Q9H9Y6 | |
| QLLEAEYYQLGVEVS | 2041 | Q68DK2 | |
| DYQGLYVTLVTLLDL | 126 | Q9P2D8 | |
| YLAVERLISGDYEID | 111 | Q9BRI3 | |
| RLILYNDGDSLQYIE | 441 | P53350 | |
| YLVETEDGYILCLNR | 51 | P38571 | |
| ANVDESLLGYLTKYD | 516 | Q6IA69 | |
| YARGKEAIETQLAEY | 401 | O14777 |